Central Garden & Pet (CENT)
(Delayed Data from NSDQ)
$42.08 USD
+2.29 (5.76%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $42.08 0.00 (0.00%) 7:08 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$42.08 USD
+2.29 (5.76%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $42.08 0.00 (0.00%) 7:08 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Zacks News
Alto Ingredients (ALTO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of -866.67% and 2.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds
by Sumit Singh
Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.
Here's Why You Should Hold Central Garden & Pet (CENT) Stock
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Central Garden & Pet's (CENT) Buyouts & E-Commerce Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. CENT is also steadily advancing its digital capabilities and focusing on marketing activities.
Why Is Central Garden (CENT) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Beat on Earnings & Sales in Q3
by Zacks Equity Research
Central Garden & Pet's (CENT) Q3 results are affected by headwinds, including softness in the garden segment and ongoing cost inflation. However, the 'Central to Home' strategy bodes well.
Central Garden (CENT) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 10.32% and 2.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From Central Garden & Pet's (CENT) Q3 Earnings?
by Zacks Equity Research
Central Garden & Pet's (CENT) third-quarter fiscal 2022 earnings results are likely to reflect softness in the Garden portfolio.
Earnings Preview: Central Garden (CENT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Central Garden & Pet (CENT) Trims FY22 Earnings View
by Zacks Equity Research
Garden & Pet (CENT) cited unfavorable weather conditions, lower foot traffic and changing inventory expectations from customers behind sluggishness in the Garden segment.
Central Garden (CENT) Upgraded to Buy: Here's Why
by Zacks Equity Research
Central Garden (CENT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High
by Zacks Equity Research
Prestige Consumer (PBH) is benefiting from its solid brand-building efforts and growing e-commerce business.
Central Garden & Pet's (CENT) E-Commerce & Buyouts Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. The company is also steadily advancing its digital capabilities and focusing on marketing activities.
Here's Why Hanesbrands (HBI) drops More Than 25% in 3 Months
by Zacks Equity Research
Hanesbrands (HBI) is grappling with higher inflation, which is affecting its margin performance. However, unfavorable foreign currency rates are a hurdle.
Central Garden (CENT) Up 3.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts Predict a 30% Upside in Central Garden (CENT): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Central Garden (CENT) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Central Garden (CENT) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Central Garden (CENT) points to a 31.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Spectrum Brands (SPB) Q2 Earnings and Sales Top Estimates
by Zacks Equity Research
Spectrum Brands' (SPB) Q2 sales gain from strength across segments and robust price realization, while dismal margins, owing to cost inflation and supply-chain headwinds, hurt earnings.
Central Garden & Pet (CENT) Q2 Earnings Beat, Sales Up Y/Y
by Zacks Equity Research
Central Garden & Pet Company's (CENT) second-quarter results reflect investments in digital capabilities and innovation as well as customer insights to drive growth.
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 7.63% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Central Garden & Pet's (CENT) Q2 Earnings?
by Zacks Equity Research
Central Garden & Pet's (CENT) Q2 earnings are likely to reflect the impact of rising costs for key commodities, freight and labor.
Central Garden & Pet's (CENT) Brands & Buyouts Fuel Sales
by Zacks Equity Research
Central Garden & Pet's (CENT) acquisition initiative constantly strengthens its portfolio. The company is also steadily advancing its digital capabilities and focusing on marketing activities.
Are These Consumer Discretionary Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Strength Seen in The RealReal (REAL): Can Its 7.8% Jump Turn into More Strength?
by Zacks Equity Research
The RealReal (REAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.